EKZ-99968-90001
3 vaccinations
3 coded responses
17 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 366 / AL
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-04
Dose 1 — Pfizer-BioNTech
-
2021-02-25
Dose 2 — Pfizer-BioNTech
-
2021-02-27
Registered in v-safe
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-02-28
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
-
2021-04-01
Survey response — day 35, dose 2MedDRA: Cough, Paranasal sinus hypersecretion — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cough, sinus drainageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-10
- 2021-05-29
- 2021-06-15
-
2022-01-22
Dose 3 — Pfizer-BioNTech
-
2022-01-23
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-01-28
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fever · Headache, Fatigue or tirednessAdult check-in
-
2022-02-05
Survey response — day 14, dose 3MedDRA: Abdominal discomfort — Feeling: FairFree text: Upset stomachMedDRA releases: 2024-11 · check-in free text available
- 2022-02-12
-
2022-07-23
Survey response — 6 months, dose 3MedDRA: Cough, Headache, Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to work or attend schoolFree text: Cough, runny nose, fever, body aches, headaches, sore throatMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Pfizer-BioNTech | |
| 2 | 2021-02-25 | Pfizer-BioNTech | |
| 3 | 2022-01-22 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — day 35, dose 2
Symptoms: Cough, sinus drainage
Release 11 — day 14, dose 3
Symptoms: Upset stomach
Release 12 — 6 months, dose 3
Symptoms: Cough, runny nose, fever, body aches, headaches, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release